(2S,4S)-1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-cyclopropyl-4-pyridin-3-yloxypyrrolidine-2-carboxamide
C19H19N5O4S2 — CID 110199053
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,4S)-1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-cyclopropyl-4-pyridin-3-yloxypyrrolidine-2-carboxamide
(2S,4S)-1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-cyclopropyl-4-pyridin-3-yloxypyrrolidine-2-carboxamide (PubChem CID 110199053) has the molecular formula C19H19N5O4S2 and a molecular weight of 445.53 g/mol. Its IUPAC name is (2S,4S)-1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-cyclopropyl-4-pyridin-3-yloxypyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S,4S)-1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-cyclopropyl-4-pyridin-3-yloxypyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 110199053 |
| Molecular Formula | C19H19N5O4S2 |
| Molecular Weight | 445.53 g/mol |
| Exact Mass | 445.09 |
| IUPAC Name | (2S,4S)-1-(2,1,3-benzothiadiazol-4-ylsulfonyl)-N-cyclopropyl-4-pyridin-3-yloxypyrrolidine-2-carboxamide |
| SMILES | O=C(NC1CC1)[C@@H]1C[C@H](Oc2cccnc2)CN1S(=O)(=O)c1cccc2nsnc12 |
| InChI | InChI=1S/C19H19N5O4S2/c25-19(21-12-6-7-12)16-9-14(28-13-3-2-8-20-10-13)11-24(16)30(26,27)17-5-1-4-15-18(17)23-29-22-15/h1-5,8,10,12,14,16H,6-7,9,11H2,(H,21,25)/t14-,16-/m0/s1 |
| InChIKey | MHWLYQQJYWNIOS-HOCLYGCPSA-N |
| XLogP | 1.58 |
| TPSA | 114.38 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.53 |
| LogP ≤ 5 | 1.58 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 110199053 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.